These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 11531415)

  • 21. Influence of human immunodeficiency virus type 1 envelope glycoprotein YXXL endocytosis/polarization signal on viral accessory protein functions.
    Cervantes-Acosta G; Lodge R; Lemay G; Cohen EA
    J Hum Virol; 2001; 4(5):249-59. PubMed ID: 11907382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The second extracellular loop of CCR5 contains the dominant epitopes for highly potent anti-human immunodeficiency virus monoclonal antibodies.
    Zhang J; Rao E; Dioszegi M; Kondru R; DeRosier A; Chan E; Schwoerer S; Cammack N; Brandt M; Sankuratri S; Ji C
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1386-97. PubMed ID: 17242138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular anatomy of CCR5 engagement by physiologic and viral chemokines and HIV-1 envelope glycoproteins: differences in primary structural requirements for RANTES, MIP-1 alpha, and vMIP-II Binding.
    Navenot JM; Wang ZX; Trent JO; Murray JL; Hu QX; DeLeeuw L; Moore PS; Chang Y; Peiper SC
    J Mol Biol; 2001 Nov; 313(5):1181-93. PubMed ID: 11700073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Biological characteristics of HIV-1 isolates circulating in China are linked to its env V3 loop sequence variability].
    Hei FX; Hong KX; Song YH; Tang HL; Peng H; Xu JQ; Xing H; Shao YM
    Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(23):1968-72. PubMed ID: 15730807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic characterization of accessory genes from human immunodeficiency virus type 1 group O strains.
    Bibollet-Ruche F; Loussert-Ajaka I; Simon F; Mboup S; Ngole EM; Saman E; Delaporte E; Peeters M
    AIDS Res Hum Retroviruses; 1998 Jul; 14(11):951-61. PubMed ID: 9686641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Replicative fitness of CCR5-using and CXCR4-using human immunodeficiency virus type 1 biological clones.
    Ariën KK; Gali Y; El-Abdellati A; Heyndrickx L; Janssens W; Vanham G
    Virology; 2006 Mar; 347(1):65-74. PubMed ID: 16386774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential inhibition of human immunodeficiency virus type 1 fusion, gp120 binding, and CC-chemokine activity by monoclonal antibodies to CCR5.
    Olson WC; Rabut GE; Nagashima KA; Tran DN; Anselma DJ; Monard SP; Segal JP; Thompson DA; Kajumo F; Guo Y; Moore JP; Maddon PJ; Dragic T
    J Virol; 1999 May; 73(5):4145-55. PubMed ID: 10196311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rev is necessary for translation but not cytoplasmic accumulation of HIV-1 vif, vpr, and env/vpu 2 RNAs.
    Arrigo SJ; Chen IS
    Genes Dev; 1991 May; 5(5):808-19. PubMed ID: 1827422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adaptive mutations in a human immunodeficiency virus type 1 envelope protein with a truncated V3 loop restore function by improving interactions with CD4.
    Agrawal-Gamse C; Lee FH; Haggarty B; Jordan AP; Yi Y; Lee B; Collman RG; Hoxie JA; Doms RW; Laakso MM
    J Virol; 2009 Nov; 83(21):11005-15. PubMed ID: 19692476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential use of CCR5 by HIV-1 clinical isolates resistant to small-molecule CCR5 antagonists.
    Henrich TJ; Lewine NR; Lee SH; Rao SS; Berro R; Gulick RM; Moore JP; Tsibris AM; Kuritzkes DR
    Antimicrob Agents Chemother; 2012 Apr; 56(4):1931-5. PubMed ID: 22252820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIV accessory proteins: emerging therapeutic targets.
    Miller RH; Sarver N
    Mol Med; 1995 Jul; 1(5):479-85. PubMed ID: 8529114
    [No Abstract]   [Full Text] [Related]  

  • 32. Replication and pathogenicity of human immunodeficiency virus type 1 accessory gene mutants in SCID-hu mice.
    Aldrovandi GM; Zack JA
    J Virol; 1996 Mar; 70(3):1505-11. PubMed ID: 8627668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Consistent risk group-associated differences in human immunodeficiency virus type 1 vpr, vpu and V3 sequences despite independent evolution.
    Kuiken CL; Cornelissen MT; Zorgdrager F; Hartman S; Gibbs AJ; Goudsmit J
    J Gen Virol; 1996 Apr; 77 ( Pt 4)():783-92. PubMed ID: 8627267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vpr is preferentially targeted by CTL during HIV-1 infection.
    Altfeld M; Addo MM; Eldridge RL; Yu XG; Thomas S; Khatri A; Strick D; Phillips MN; Cohen GB; Islam SA; Kalams SA; Brander C; Goulder PJ; Rosenberg ES; Walker BD;
    J Immunol; 2001 Sep; 167(5):2743-52. PubMed ID: 11509618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. When accessories turn out to be essential.
    Trono D
    Nat Med; 1998 Dec; 4(12):1368-9. PubMed ID: 9846571
    [No Abstract]   [Full Text] [Related]  

  • 36. An anti-CCR5 monoclonal antibody and small molecule CCR5 antagonists synergize by inhibiting different stages of human immunodeficiency virus type 1 entry.
    Safarian D; Carnec X; Tsamis F; Kajumo F; Dragic T
    Virology; 2006 Sep; 352(2):477-84. PubMed ID: 16777164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Continued utilization of CCR5 coreceptor by a newly derived T-cell line-adapted isolate of human immunodeficiency virus type 1.
    Follis KE; Trahey M; LaCasse RA; Nunberg JH
    J Virol; 1998 Sep; 72(9):7603-8. PubMed ID: 9696861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A virion-specific inhibitory molecule with therapeutic potential for human immunodeficiency virus type 1.
    Matsuda Z; Yu X; Yu QC; Lee TH; Essex M
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3544-8. PubMed ID: 7682710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Codon-optimized reading frames facilitate high-level expression of the HIV-1 minor proteins.
    Anson DS; Dunning KR
    Mol Biotechnol; 2005 Sep; 31(1):85-8. PubMed ID: 16118417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular biology of the human immunodeficiency virus accessory proteins.
    Subbramanian RA; Cohen EA
    J Virol; 1994 Nov; 68(11):6831-5. PubMed ID: 7933064
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.